ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 852 filers reported holding ISHARES TR in Q2 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,198,024 | -14.0% | 50,683 | -10.7% | 0.64% | -11.6% |
| Q2 2023 | $7,203,837 | +0.7% | 56,741 | +2.5% | 0.72% | -3.5% |
| Q1 2023 | $7,151,718 | -14.7% | 55,371 | -13.3% | 0.74% | -17.1% |
| Q4 2022 | $8,383,129 | +27.9% | 63,852 | +14.0% | 0.90% | +19.3% |
| Q3 2022 | $6,553,000 | +18.4% | 56,028 | +19.0% | 0.75% | +32.9% |
| Q2 2022 | $5,536,000 | -6.4% | 47,070 | +3.7% | 0.57% | +9.3% |
| Q1 2022 | $5,912,000 | +643.6% | 45,377 | +771.3% | 0.52% | +673.1% |
| Q4 2021 | $795,000 | +15.7% | 5,208 | +22.6% | 0.07% | +3.1% |
| Q3 2021 | $687,000 | -1.6% | 4,249 | -0.3% | 0.06% | -3.0% |
| Q2 2021 | $698,000 | +82.7% | 4,263 | +68.2% | 0.07% | +71.8% |
| Q1 2021 | $382,000 | -8.2% | 2,535 | -7.7% | 0.04% | -9.3% |
| Q4 2020 | $416,000 | +5.3% | 2,745 | -5.9% | 0.04% | -6.5% |
| Q3 2020 | $395,000 | +19.0% | 2,918 | +20.1% | 0.05% | +12.2% |
| Q2 2020 | $332,000 | – | 2,430 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Elliott Investment Management L.P. | 4,617,600 | $564,686,304 | 4.37% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 57,250 | $7,001,103 | 4.35% |
| DAFNA Capital Management LLC | 102,500 | $12,534,725 | 3.90% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,306,775 | 3.58% |
| Rye Brook Capital LLC | 40,900 | $5,002 | 3.56% |
| Bronte Capital Management Pty Ltd. | 283,229 | $34,636,074 | 3.49% |
| FWL INVESTMENT MANAGEMENT, LLC | 39,504 | $4,830,944 | 3.24% |
| Alpha Family Trust | 34,568 | $4,227,321 | 3.22% |
| HARBOUR INVESTMENT MANAGEMENT LLC | 40,720 | $4,985,830 | 2.85% |
| CUMBERLAND ADVISORS INC | 51,490 | $6,296,712 | 2.79% |